Clinical Trials Directory

Trials / Completed

CompletedNCT04288401

Prevalence of Osteosarcopenic Obesity in Older Adults

Prevalence of Osteosarcopenic Obesity in Older Community-dwelling Adults in Turkey

Status
Completed
Phase
Study type
Observational
Enrollment
460 (actual)
Sponsor
Istanbul Medeniyet University · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

Osteosarcopenic Obesity (OSO) is a syndrome characterized by the loss of bone and muscle in addition to increase in the fat tissue as a result of aging process. It is the latest point of impairment in the bone,muscle and adipose tissue in older adults. OSO, as the name suggests, is the combination of three syndrome frequently encountered in the elderly: osteopenia/osteoporosis, sarcopenia and obesity. The aims of study are to determine the prevalence of OSO syndrome in community-dwelling adults of Turkey and determine the possible factors regarding risk of falling in this population

Conditions

Timeline

Start date
2020-02-25
Primary completion
2020-03-31
Completion
2020-04-01
First posted
2020-02-28
Last updated
2020-05-19

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04288401. Inclusion in this directory is not an endorsement.

Prevalence of Osteosarcopenic Obesity in Older Adults (NCT04288401) · Clinical Trials Directory